Sleep Disorder Market

Fatpos Global has released a report titled “Sleep Disorder Market - Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2031” which is anticipated to reach USD 12.2 billion by 2031. According to a study by Fatpos Global, the market is anticipated to portray a CAGR of 7.5% between 2021 and 2031. According to the report, mental stress is increasing due to hectic life & unhealthy habits are anticipated to propel the growth of the sleep disorder market. Furthermore, the growing usage of social media and increasing addiction to gadgets such as smartphones and laptops augment the market. In addition, the rise in public and private health coverage, covering sleep clinics is boosting the market.

The market report on the global Sleep Disorder Market includes in-depth insights as:

• The market's estimated value was USD 5.9 billion in the year 2021.
• Global Sleep Disorder in North America held the largest market share in the year 2020.
• Based on Disorder, the global Sleep Disorder Market is fragmented into Insomnia, Hypersomnia, Sleep Apnea, Sleep Breathing Disorders, Circadian Rhythm Disorders, Parasomnia, Sleep Movement Disorders.
• Global Sleep Disorder market is classified based on Devices into Sleep Apnea Devices, Sleep Laboratories, Mattresses & Pillows
• Based on Treatment, the global Sleep Disorder Market is fragmented into Psychiatric Treatment, Behavioral Treatment, Cognitive Behavioral Therapy, Medication Therapy
• Key players are likely to focus on product innovations and expansion through mergers to retain their positions in developed markets.

“One of the major factors driving the sleep disorder market is increasing awareness about sleep disease among the people and government of different nations is expected to propel the sleep disorders treatment market. The increasing number of people suffering from various sleep disorders, including hallucinations, sleep paralysis, disrupted nocturnal sleep, insomnia, sleep apnea, narcolepsy, and circadian disorders, caught the attention of governments globally, pushing them to take necessary steps to address this condition.”, said a lead analyst at Fatpos Global.

Based on Devices, the global Sleep Disorder Market is fragmented into Sleep Apnea Devices, Sleep Laboratories, Mattresses & Pillows. Sleep apnea devices are estimated to share the highest market in terms of revenue. Growing demand for early treatment and increasing patient awareness are the major factors estimated to boost the demand for such devices. Furthermore, a large number of patient pools seeking effective diagnoses and treatments are expected to generate lucrative market growth opportunities.

Key Players in the Market

Some of the key players operating in the global Sleep Disorder Market are GlaxoSmithKline plc, Becton Dickson and Company, Cardinal Health, Natus Medical Incorporated Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., and Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc, Cadwell Laboratories Inc., and Other Prominent Players    

Get Valuable Insights into Global Sleep Disorder Market

In the new report, Fatpos Global thrives to present an unbiased analysis of the global Sleep Disorder Market that covers the historical demand data as well as the forecast figures for the period, i.e., 2021-2031. The study includes compelling insights into growth that is witnessed in the market. Based on Disorders, the global Sleep Disorder Market is fragmented Insomnia, Hypersomnia, Sleep Apnea, Sleep Breathing Disorders, Circadian Rhythm Disorders, Parasomnia, Sleep Movement Disorders. The Global Sleep Disorder market is classified based on Devices into Sleep Apnea Devices, Sleep Laboratories, Mattresses & Pillows. Based on Treatment, the global Sleep Disorder Market is fragmented into Psychiatric Treatment, Behavioral Treatment, Cognitive Behavioral Therapy, Medication Therapy. Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East, and Africa.